Predict your next investment

HEALTHCARE | Drug Delivery
aquariusbio.com

See what CB Insights has to offer

Stage

Unattributed | Alive

Total Raised

$320K

Last Raised

$320K | 8 yrs ago

About Aquarius Biotechnologies

Aquarius Biotechnologies is founded on a drug delivery platform called "cochleates." When applied to existing drugs, cochleates have demonstrated the ability to address both of the issues highlighted above by: 1) creating oral drug alternatives with non-inferior efficacy for drugs that are currently only available via IV and 2) reducing the toxicity of drugs.

Aquarius Biotechnologies Headquarter Location

2037 W Carroll Avenue

Chicago, Illinois, 60612,

United States

903-399-1553

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Aquarius Biotechnologies Patents

Aquarius Biotechnologies has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/29/2015

6/21/2016

Alkene derivatives, Calcium channel blockers, Membrane biology, Serotonin receptor agonists, Piperidines

Grant

Application Date

1/29/2015

Grant Date

6/21/2016

Title

Related Topics

Alkene derivatives, Calcium channel blockers, Membrane biology, Serotonin receptor agonists, Piperidines

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.